Volume 22, Issue 9, Pages (September 2014)

Slides:



Advertisements
Similar presentations
Volume 17, Issue 1, Pages (January 2010)
Advertisements

Structural Basis of Interdomain Communication in the Hsc70 Chaperone
Structural Basis for the Highly Selective Inhibition of MMP-13
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
The TNF and TNF Receptor Superfamilies
Volume 27, Issue 4, Pages (October 2007)
Structure of an LDLR-RAP Complex Reveals a General Mode for Ligand Recognition by Lipoprotein Receptors  Carl Fisher, Natalia Beglova, Stephen C. Blacklow 
Volume 25, Issue 8, Pages e4 (August 2017)
Volume 21, Issue 5, Pages (May 2013)
Volume 25, Issue 11, Pages e2 (November 2017)
Volume 25, Issue 8, Pages (August 2017)
Volume 22, Issue 9, Pages (September 2014)
Structural Basis for Dimerization in DNA Recognition by Gal4
Volume 21, Issue 9, Pages (September 2013)
Xiaojing He, Yi-Chun Kuo, Tyler J. Rosche, Xuewu Zhang  Structure 
Chaperone-Assisted Crystallography with DARPins
Decoy Strategies: The Structure of TL1A:DcR3 Complex
Yvonne Groemping, Karine Lapouge, Stephen J. Smerdon, Katrin Rittinger 
Volume 24, Issue 8, Pages (August 2016)
Allosteric Effects of the Oncogenic RasQ61L Mutant on Raf-RBD
Volume 23, Issue 7, Pages (July 2015)
Volume 23, Issue 2, Pages (February 2015)
Volume 19, Issue 12, Pages (December 2011)
Volume 28, Issue 1, Pages (October 2007)
Volume 24, Issue 5, Pages (May 2016)
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Hong Ye, Young Chul Park, Mara Kreishman, Elliott Kieff, Hao Wu 
Structural Insights into the Inhibition of Wnt Signaling by Cancer Antigen 5T4/Wnt- Activated Inhibitory Factor 1  Yuguang Zhao, Tomas Malinauskas, Karl.
A Conformational Switch in the CRIB-PDZ Module of Par-6
Structural Basis for the Differential Effects of CaBP1 and Calmodulin on CaV1.2 Calcium-Dependent Inactivation  Felix Findeisen, Daniel L. Minor  Structure 
Volume 124, Issue 5, Pages (March 2006)
The Crystal Structure of the Costimulatory OX40-OX40L Complex
Structural Basis of Prion Inhibition by Phenothiazine Compounds
Structure of the Human IgE-Fc Cε3-Cε4 Reveals Conformational Flexibility in the Antibody Effector Domains  Beth A. Wurzburg, Scott C. Garman, Theodore.
Sanjay B. Hari, Ethan A. Merritt, Dustin J. Maly  Chemistry & Biology 
Crystal Structure of Full-Length Apaf-1: How the Death Signal Is Relayed in the Mitochondrial Pathway of Apoptosis  Thomas Frank Reubold, Sabine Wohlgemuth,
Elizabeth J. Little, Andrea C. Babic, Nancy C. Horton  Structure 
André Schiefner, Michaela Gebauer, Antonia Richter, Arne Skerra 
Jiao Yang, Melesse Nune, Yinong Zong, Lei Zhou, Qinglian Liu  Structure 
Volume 25, Issue 8, Pages e4 (August 2017)
Structural Basis of EZH2 Recognition by EED
Volume 18, Issue 5, Pages (May 2010)
Crystal Structure of the p53 Core Domain Bound to a Full Consensus Site as a Self- Assembled Tetramer  Yongheng Chen, Raja Dey, Lin Chen  Structure  Volume.
Structural Basis for the Highly Selective Inhibition of MMP-13
Crystal Structures of the BAR-PH and PTB Domains of Human APPL1
Meigang Gu, Kanagalaghatta R. Rajashankar, Christopher D. Lima 
Volume 23, Issue 6, Pages (June 2015)
Volume 23, Issue 9, Pages (September 2015)
Volume 14, Issue 4, Pages (April 2006)
Volume 52, Issue 3, Pages (November 2013)
Michael S. Kuhns, Mark M. Davis  Immunity 
Structural Insight into AMPK Regulation: ADP Comes into Play
Structure of the Staphylococcus aureus AgrA LytTR Domain Bound to DNA Reveals a Beta Fold with an Unusual Mode of Binding  David J. Sidote, Christopher.
Volume 24, Issue 6, Pages (June 2016)
Ying Huang, Michael P. Myers, Rui-Ming Xu  Structure 
Volume 17, Issue 1, Pages (January 2009)
Structural Role of the Vps4-Vta1 Interface in ESCRT-III Recycling
Volume 132, Issue 2, Pages (January 2008)
Volume 19, Issue 8, Pages (August 2011)
Volume 23, Issue 9, Pages (September 2015)
Volume 127, Issue 7, Pages (December 2006)
Volume 13, Issue 5, Pages (May 2005)
Volume 21, Issue 8, Pages (August 2013)
Petra Hänzelmann, Hermann Schindelin  Structure 
Yogesh K. Gupta, Deepak T. Nair, Robin P. Wharton, Aneel K. Aggarwal 
Alternate Modes of Cognate RNA Recognition by Human PUMILIO Proteins
Structure of the Mtb CarD/RNAP β-Lobes Complex Reveals the Molecular Basis of Interaction and Presents a Distinct DNA-Binding Domain for Mtb CarD  Gulcin.
Volume 15, Issue 5, Pages (May 2007)
Structural Basis for Apelin Control of the Human Apelin Receptor
A Potential Protein-RNA Recognition Event along the RISC-Loading Pathway from the Structure of A. aeolicus Argonaute with Externally Bound siRNA  Yu-Ren.
Presentation transcript:

Volume 22, Issue 9, Pages 1252-1262 (September 2014) Mechanistic Basis for Functional Promiscuity in the TNF and TNF Receptor Superfamilies: Structure of the LIGHT:DcR3 Assembly  Weifeng Liu, Chenyang Zhan, Huiyong Cheng, P. Rajesh Kumar, Jeffrey B. Bonanno, Stanley G. Nathenson, Steven C. Almo  Structure  Volume 22, Issue 9, Pages 1252-1262 (September 2014) DOI: 10.1016/j.str.2014.06.013 Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 1 The Interaction Network of LIGHT and DcR3 within the TNF/TNFR Superfamilies TNF ligands FasL (orange), LIGHT (blue), and TL1A (magenta) bind to Fas (light orange), DR3 (dark magenta), and HVEM (green) and LTβR (dark blue), respectively, transducing proliferative (+) or apoptotic (−) signals to different cell types. Engagement of TL1A with DR3 expressed on T cells promotes proliferation, whereas interaction of TL1A with DR3 expressed on osteoblasts induces apoptosis. The signals transduced by FasL, LIGHT, and TL1A can all be blocked by DcR3 (red), which competes for binding with the cognate signaling receptors. See also Figure S7. Structure 2014 22, 1252-1262DOI: (10.1016/j.str.2014.06.013) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 2 Overall Structure and Determinants of LIGHT: DcR3 Recognition (A) Side view (top) and bottom view (bottom) of the overall structure of LIGHT:DcR3 complex. LIGHT is shown as a cartoon (blue and red), and DcR3 is shown as surface (gray). One LIGHT homotrimer binds three DcR3 molecules at interprotomer interfaces. (B) The GH loop (magenta) makes polar contacts with DcR3 (gray and green). (C) The DE loop (magenta) makes polar contacts with DcR3 (gray and green). See also Figure S3. Structure 2014 22, 1252-1262DOI: (10.1016/j.str.2014.06.013) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 3 Comparison of the Structures of the LIGHT:DcR3 and TL1A:DcR3 Complexes Reveals Similar Interaction Determinants on Both Ligand and Receptor The upper and lower regions are separated by a blue dashed line. The upper region of the interface is colored blue. The DE loop of the lower region is colored yellow, and the other parts of the lower region are colored red. (A) “Open-book” view of LIGHT:DcR3 binding surfaces. The DcR3 molecule was rotated around one axis by 180° to expose the binding interface. (B) “Open-book” view of TL1A:DcR3 binding surfaces. (C) Alignment of the three DcR3 ligands LIGHT, TL1A, and FasL shows less than 35% sequence identity. The binding residues shaded red, yellow, and blue in (A) and (B) are correspondingly colored. See also Figure S4. Structure 2014 22, 1252-1262DOI: (10.1016/j.str.2014.06.013) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 4 DcR3-Dependent Conformational Changes of LIGHT (A) Zoom-in view of the DE loop shows significant DcR3-dependent structural alterations. (B) Superposition of LIGHT unbound (green) or bound (magenta) with DcR3 shows slight changes in the two parallel beta-sheets (blue) but significant conformational changes in the loops. (C) Zoom in view of the AA′ and GH loops shows significant DcR3-dependent structural alterations. See also Figure S8. Structure 2014 22, 1252-1262DOI: (10.1016/j.str.2014.06.013) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 5 Rationale for Designing LIGHT Mutants TL1A (red ribbon) and LIGHT (blue ribbon) both bind to DcR3; LIGHT also binds HVEM and LTβR, while TL1A does not. Loop transplantation of the binding sites from TL1A to LIGHT result in chimeric proteins which possess binding to DcR3 but reduced interactions with HVEM and LTβR. See also Figure S2. Structure 2014 22, 1252-1262DOI: (10.1016/j.str.2014.06.013) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 6 Biological Activities of LIGHT on HT-29 Tumor Cells (A) Fluorescence-activated cell sorting analysis of the apoptosis of HT-29 cells. The population of late apoptotic cells is indicated as propidium iodide and annexin-V double-positive events in the upper right quadrant. (B) The apoptosis percentages of HT-29 from different treatments (wild-type and mutants) at protein concentrations of 100 ng/ml. Stars indicate p values below 0.05% by paired t test; error bars are calculated from experiments performed in triplicate. (C) The effect of different treatments on inhibition of HT-29 growth at protein concentrations of 100 ng/ml. (D) The apoptosis percentage of HT-29 from treatments at different protein concentrations (0, 50, 100, and 200 ng/ml). Stars indicate p values below 0.05% by paired t test; error bars are calculated from experiments performed in triplicate. See also Figure S1. Structure 2014 22, 1252-1262DOI: (10.1016/j.str.2014.06.013) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 7 LIGHT:DcR3 Forms Interlocking Hexamers Similar to Those Observed in TNF:TNFR2, PDB Entry 3ALQ The ligands LIGHT and TNF are both shown as surface representations. The receptors DcR3 and TNFR2 are shown as ribbons. (A) Side view of the LIGHT:DcR3 complex. For clarity, one canonical LIGHT:DcR3 hexamer is colored gray (LIGHT) and cyan (DcR3), and the other is colored yellow (LIGHT) and orange (DcR3). (B) Side view of the TNF:TNFR2 complex. For clarity, one canonical TNF:TNFR2 hexamer is colored light blue (TNF) and teal (TNFR2) and the other is colored red (TNF) and salmon (TNFR2). (C) Bottom view of the interlocking hexamers of LIGHT:DcR3 complex. (D) Boom view of the interlocking hexamers of the TNF:TNFR2 complex. See also Figure S6. Structure 2014 22, 1252-1262DOI: (10.1016/j.str.2014.06.013) Copyright © 2014 Elsevier Ltd Terms and Conditions